Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:55:45 EDT Mon 13 Jul 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:CJMB - CALLAN JMB INC - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CJMB - Q12.00.662·0.7950.10.7325-0.0551-7.040.1225310.741  0.7853  0.68155.88  0.650511:34:59Jul 0815 min RT 2¢

Recent Trades - Last 10 of 531
Time ETExPriceChangeVolume
11:34:59Q0.75-0.01613
11:34:03Q0.75-0.01613
11:33:42Q0.75-0.01613
11:33:39Q0.75-0.01613
11:33:24Q0.75-0.01613
11:33:10Q0.75-0.016149
11:32:46Q0.75-0.01613
11:32:43Q0.75-0.01613
11:32:17Q0.7323-0.03382
11:32:17Q0.7325-0.0551404

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-07-08 17:05U:CJMBNews ReleaseCallan JMB Inc. and Alabama State University Partner to Advance Workforce Development, Research, and Pharmaceutical Innovation at the Atlas Complex
2026-06-11 08:45U:CJMBNews ReleaseCallan JMB Expands Oregon Public Health Support Capabilities Through State VFC Authorization
2026-05-20 09:00U:CJMBNews ReleaseCallan JMB Expands Long-Standing Public Sector Infrastructure Engagement
2026-04-20 08:00U:CJMBNews ReleaseCallan JMB Launches The Atlas Complex in Alabama to Successfully Achieve the Capture of Significant Pharmaceutical Onshoring Demand and Expand U.S. Supply Chain Infrastructure
2026-04-17 17:00U:CJMBNews ReleaseCallan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC
2026-04-07 08:45U:CJMBNews ReleaseCallan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer
2026-03-31 16:05U:CJMBNews ReleaseCallan JMB Reports Full Year 2025 Financial Results and Provides Business Update
2026-03-27 08:45U:CJMBNews ReleaseCallan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement
2026-03-11 08:45U:CJMBNews ReleaseCallan JMB Inc. to Oversee Manufacturing and Quality Control of Attune Biotech's IND Clinical Trials for lodonal(TM) in the Treatment of Long COVID
2026-03-02 08:45U:CJMBNews ReleaseCallan JMB CEO, Wayne Williams Invited to Attend the 50th International GMP Conference on March 2-5, 2026
2026-02-27 08:45U:CJMBNews ReleaseCallan JMB Announces Participation in the iAccess Alpha Virtual Best Ideas Spring Investment Conference on March 10-11, 2026
2026-01-20 09:00U:CJMBNews ReleaseCallan JMB Announces Participation in the DealFlow Discovery Conference on January 28-29, 2026
2026-01-15 08:45U:CJMBNews ReleaseCallan JMB Signs Manufacturing Oversight, Federal Deployment, and Commercialization Agreement of Multi-Asset Therapeutic Pipeline with Attune for Approximately $50 to $75 Million in Total Revenue
2026-01-12 08:00U:CJMBNews ReleaseCallan JMB Inc. (NASDAQ:CJMB) Announces Major Strategic Pivot to Cold-Chain Infrastructure for the $100 Billion GLP-1 Pharmaceutical Market; Initiates Retrofitting of Texas cGMP Facility
2025-11-14 16:05U:CJMBNews ReleaseCallan JMB Announces Third Quarter 2025 Financial Results and Provides Business Update
2025-11-13 09:00U:CJMBNews ReleaseCallan JMB Enters Agreement to Install Oral Drug Delivery Equipment in Texas Facility
2025-11-10 08:45U:CJMBNews ReleaseCallan JMB Expands Logistics Platform Into Food Sampling Sector, Advancing Multi-Variant Growth Strategy
2025-10-13 09:00U:CJMBNews ReleaseCallan JMB Upgrades Sentry Monitoring System Technology with Sentry 4 for Mobile Temperature Monitoring
2025-10-10 09:00U:CJMBNews ReleaseCallan JMB Announces Participation in the LD Micro Main Event XIX Conference on October 19-21, 2025
2025-09-02 09:00U:CJMBNews ReleaseCallan JMB to Participate in Upcoming September Conferences